Teleflex Incorporated (NYSE:TFX) Receives $252.50 Consensus Target Price from Brokerages

Shares of Teleflex Incorporated (NYSE:TFX) have been assigned a consensus rating of “Moderate Buy” from the seven ratings firms that are currently covering the stock, Marketbeat.com reports. Three analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 12 month price target among brokers that have issued a report on the stock in the last year is $252.50.

TFX has been the subject of several research analyst reports. Needham & Company LLC reaffirmed a “hold” rating on shares of Teleflex in a research note on Monday, December 16th. Mizuho cut their target price on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research note on Friday, November 1st. Truist Financial lowered their price objective on shares of Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a research report on Wednesday, December 18th. StockNews.com upgraded shares of Teleflex from a “hold” rating to a “buy” rating in a research report on Thursday, November 28th. Finally, Royal Bank of Canada lowered their price objective on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research report on Friday, November 1st.

Teleflex Stock Performance

Shares of NYSE TFX opened at $167.44 on Thursday. The firm has a fifty day moving average price of $178.15 and a 200-day moving average price of $209.23. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39. The stock has a market cap of $7.78 billion, a PE ratio of 33.29, a price-to-earnings-growth ratio of 1.72 and a beta of 1.16. Teleflex has a 1 year low of $166.76 and a 1 year high of $256.85.

Institutional Investors Weigh In On Teleflex

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. T. Rowe Price Investment Management Inc. lifted its holdings in Teleflex by 4.4% during the 4th quarter. T. Rowe Price Investment Management Inc. now owns 6,173,121 shares of the medical technology company’s stock valued at $1,098,693,000 after buying an additional 261,279 shares in the last quarter. Janus Henderson Group PLC increased its position in Teleflex by 2.8% during the 3rd quarter. Janus Henderson Group PLC now owns 5,376,452 shares of the medical technology company’s stock valued at $1,329,704,000 after purchasing an additional 147,147 shares during the period. State Street Corp increased its position in Teleflex by 1.0% during the 3rd quarter. State Street Corp now owns 2,057,080 shares of the medical technology company’s stock valued at $508,757,000 after purchasing an additional 21,291 shares during the period. Geode Capital Management LLC increased its position in Teleflex by 0.7% during the 4th quarter. Geode Capital Management LLC now owns 1,138,867 shares of the medical technology company’s stock valued at $202,161,000 after purchasing an additional 8,307 shares during the period. Finally, Cooke & Bieler LP increased its position in Teleflex by 22.1% during the 4th quarter. Cooke & Bieler LP now owns 1,078,557 shares of the medical technology company’s stock valued at $191,962,000 after purchasing an additional 195,150 shares during the period. Institutional investors own 95.62% of the company’s stock.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.